Stemline Therapeutics Inc (NASDAQ:STML)

16.85
Delayed Data
As of 4:00pm ET
 +0.15 / +0.90%
Today’s Change
7.30
Today|||52-Week Range
18.75
+8.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues299.4K299.4K299.4K0.00
 
 
 
 
Depreciation And Amortization952.00953.00952.0011.8K
 
 
 
 
 
 
Operating ExpensesGross Income-------11.8K
 
 
General Expenses15.0M16.0M16.6M21.9M
 
 
 
 
 
Research And Development9.6M11.5M12.4M16.7M
 
 
 
 
 
Total Operating Expenses15.0M16.0M16.6M21.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.7M-15.7M-16.3M-21.9M
 
 
 
 
 
Other Expenses0.000.00-3.2K-3.1K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.6M-15.5M-16.1M-21.7M
 
 
 
 
 
Net Income-14.6M-15.5M-16.1M-21.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.8M23.4M23.5M23.5M
 
 
 
 
 
Shares To Calculate EPS Diluted21.8M23.4M23.5M23.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.67-$0.66-$0.68-$0.93
 
 
 
 
 
EPS Diluted-$0.67-$0.66-$0.68-$0.92